doi:10.16139/j.1007-9610.2019.01.001

[1] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J]. CA Cancer J Clin,2016,66(2):115-132.
[2] Joo MK, Park JJ, Chun HJ, et al.Recent updates of precision therapy for gastric cancer: Towards optimal tailored management[J]. World J Gastroenterol,2016,22(19):4638-4650.
[3] Fujitani K, Yang HK, Mizusawa J, et al.Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial[J]. Lancet Oncol,2016,17(3):309-318.
[4] Yoshida K, Yamaguchi K, Okumura N, et al.Is conversion therapy possible in stage Ⅳ gastric cancer: the proposal of new biological categories of classification[J]. Gastric Cancer,2016,19(2):329-338.
[5] Yamaguchi K, Yoshida K, Tanaka Y, et al.Conversion therapy for stage Ⅳ gastric cancer-the present and future[J]. Transl Gastroenterol Hepatol,2016,1:50.
[6] Yamaguchi K, Yoshida K, Tanahashi T, et al.The long-term survival of stage Ⅳ gastric cancer patients with conversion therapy[J]. Gastric Cancer,2018,21(2):315-323.
[7] Sato Y, Ohnuma H, Nobuoka T, et al.Conversion therapy for inoperable advanced gastric cancer patients by doce-taxel, cisplatin, and S-1(DCS)chemotherapy: a multi-institutional retrospective study[J]. Gastric Cancer,2017,20(3):517-526.
[8] 陈凜, 郗洪庆, 申伟松. 积极开展对胃癌肝转移的多学科团队综合治疗[J]. 中华胃肠外科杂志,2014,17(2):101-104.
[9] Beom SH, Choi YY, Beak SE, et al.Multidisciplinary treatment for patients with stage Ⅳ gastric cancer: the role of conversion surgery fpllowing chemotherapy[J]. BMC Cancer,2018,18(1):1116-1133.
[10] Basta YL, Baur OL, Dieren SV, et al.Is there a benefit of multidisciplinary cancer team meetings for patients with gastrointestinal malignancies?[J]. Ann Surg Oncol,2016,23(8):2430-2437.
[11] Lundsqaard Hansen M, Fallentin E, Lauridsen C, et al.Computed tomography (CT) perfusion as an early predictive marker for theratment response to neoadjuvant chemotherapy in gastroesophageal junction cancer and gastric cancer-a prospective study[J]. PLoS One,2014,9(5):e97605.
[12] 张欢, 诗涔. 胃癌CT诊断现状及进展[J]. 诊断学理论与实践,2014,13(4):372-376.
[13] Tang L, Li ZY, Li ZW, et al.Evaluating the response of gastric carcinomas to neoadjuvant chemotherapy using iodine concentration on spectral CT: a comparison with pathological regression[J]. Clin Radiol,2015,70(11):1198-1204.
[14] Won E, Shah MA, Schöder H, et al.Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: the Memorial Sloan Kettering Cancer Center experience[J]. J Gastrointest Oncol,2016,7(4),506-514.
[15] Ott K, Fink U, Becker K, et al.Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: Results of a prospective trial[J]. J Clin Oncol,2016,21(24):4604-4610.
[16] Nakamura K, Iwatsuki M, Kurashige J, et al.Circulating tumor cells in gastric cancer[J]. J Cancer Metastasis Treat,2018,4:32.
[17] Komatsu S, Kiuchi J, Imamura T, et al.Circulating microRNAs as a liquid biopsy: a next generation clinical biomarker for diagnosis of gastric cancer[J]. J Cancer Metastasis Treat,2018,4:36-45.
[18] Lee SJ, Lee J, Kim ST, et al.Circulating tumor cells are predictive of poor response to chemotherapy in metastatic gastric cancer[J]. Int J Biol Markers,2015,30(4):382-386.
[19] Tahara T, Shibata T, Okubo M, et al.Histological evalua-tion of primary lesions are independently associated with prognosis in patients with gastric cancer who receive neoadjuvent chemotherapy[J]. Oncol Lett,2017,13(6):4892-4896.
[20] Cho H, Nakamura J, Asaumi Y, et al.Long-term survival outcomes of advanced gastric cancer patients who achieved a pathological complete response with neoadjuvant chemotherapy: a systematic review of the literature[J]. Ann Surg Oncol,2015,22(3):787-792.
[21] Fujitani K, Mano M, Hirao M, et al.Posttherapy nodal status, not graded histologic response predicts survival after neoadjuvant chemotherapy for advanced gastric cancer[J]. Ann Surg Oncol,2012,19(6):1936-1943.
[22] Smyth EC, Fassan M, Cunningham D, et al.Effect of pathologic tumor response and nodal status on survival in the medical research council adjuvant gastric infusional chemotherapy trial[J]. J Clin Oncol,2016,34(23):2721-2727.
[23] Fukuchi M, Ishiguro T, Ogata K, et al.Prognostic role of conversion surgery for unresectable gastric cancer[J]. Ann Surg Oncol,2015,22(11):3618-3624.
[24] Zurleni T, Gjoni E, Altomare M, et al.Conversion surgery for gastric cancer patients: A review[J]. World J Gastrointest Oncol,2018,10(11):398-409.
[25] Ida S, Watanabe M.Conversion surgery for stage Ⅳ gastric cancer[J]. J Cancer Metastasis Treat,2018,4:22-30.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	DAI Zhiqiang, ZHENG Jinxin, TANG Zhaoqing, ZHANG Qi, GU Yuan, SHI Zhongyi, HU Guohua, SUN Yihong. Metastatic lymph node ratio to evaluate prognosis of patients with stage Ⅱ-Ⅲ gastric cancer after radical gastrectomy [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 429-434.
[2]	NIE Mingming, ZHU Zhenggang. Clinical significance of diagnostic laparoscopy on precision staging in advanced gastric cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(04): 365-370.
[3]	GUO Liangqi, YAN Zhilong, ZHANG Moucheng. Laparoscopic intragastric surgery in treating of gastric submucosal tumor and early gastric cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(04): 380-383.
[4]	LU Weihui, LIU Wei, WANG Cong, WANG Zhenglin. Effects of CXCR2 on invasion, migration and apoptosis of gastric cancer cells [J]. Journal of Surgery Concepts & Practice, 2021, 26(5): 430-436.
[5]	LIU Jingzheng, REN Zhong, HU Jianwei, QIN Wenzheng, ZHONG Yunshi, ZHOU Pinghong. Clinical effect of endoscopic full thickness resection in treatment of small gastric submucosal tumors [J]. Journal of Surgery Concepts & Practice, 2021, 26(03): 236-239.
[6]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 1-6.
[7]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 11-16.
[8]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 17-20.
[9]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 28-33.
[10]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 38-40.
[11]	YANG Zhongyin, LI Chen, LIU Wentao, SHI Min, WU Junwei, ZHENG Yanan, ZHU Zhenglun, HUA Zichen, NI Zhentian, LU Sheng, YAN Min, YAN Chao, ZHU Zhenggang. Complications of implanted subcutaneous port for intraperitoneal chemotherapy in gastric cancer patients with peritoneal metastasis and analysis of risk factors of complications [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 41-47.
[12]	LI Mei, QIU Wencai, GAO Qi, YANG Jun, JIA Zhenyi. Perioperative application of geriatric nutritional risk index in senile patients with gastrointestinal tumors [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 58-61.
[13]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 76-78.
[14]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 79-83.
[15]	. [J]. Journal of Surgery Concepts & Practice, 2020, 25(04): 341-343.